Abstract
Annual screening of asymptomatic postmenopausal women using a combination of transvaginal sonography and serum Ca-125 has been evaluated in 4 major clinical trials as a means to facilitate earlier detection of ovarian cancer. In several trials, screening has caused a decrease in stage at detection. These ovarian cancer screening trials are reviewed. The effect of screening on ovarian cancer mortality varies in different trials and is the subject of further investigation.
| Original language | English |
|---|---|
| Pages (from-to) | 43-51 |
| Number of pages | 9 |
| Journal | Clinical Obstetrics and Gynecology |
| Volume | 55 |
| Issue number | 1 |
| DOIs | |
| State | Published - Mar 2012 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- ovarian cancer detection
- ovarian screening trials
- serum Ca-125
- transvaginal sonography
ASJC Scopus subject areas
- Obstetrics and Gynecology
Fingerprint
Dive into the research topics of 'Ovarian cancer screening'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver